NM_001395002.1:c.180+15756T>C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001395002.1(MAP4K4):c.180+15756T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.158 in 152,048 control chromosomes in the GnomAD database, including 5,754 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.16 ( 5754 hom., cov: 31)
Consequence
MAP4K4
NM_001395002.1 intron
NM_001395002.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.999
Publications
3 publications found
Genes affected
MAP4K4 (HGNC:6866): (mitogen-activated protein kinase kinase kinase kinase 4) The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase has been shown to specifically activate MAPK8/JNK. The activation of MAPK8 by this kinase is found to be inhibited by the dominant-negative mutants of MAP3K7/TAK1, MAP2K4/MKK4, and MAP2K7/MKK7, which suggests that this kinase may function through the MAP3K7-MAP2K4-MAP2K7 kinase cascade, and mediate the TNF-alpha signaling pathway. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
MAP4K4 Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.514 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MAP4K4 | NM_001395002.1 | c.180+15756T>C | intron_variant | Intron 3 of 32 | ENST00000324219.9 | NP_001381931.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.157 AC: 23871AN: 151932Hom.: 5723 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
23871
AN:
151932
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.158 AC: 23948AN: 152048Hom.: 5754 Cov.: 31 AF XY: 0.152 AC XY: 11299AN XY: 74366 show subpopulations
GnomAD4 genome
AF:
AC:
23948
AN:
152048
Hom.:
Cov.:
31
AF XY:
AC XY:
11299
AN XY:
74366
show subpopulations
African (AFR)
AF:
AC:
21514
AN:
41384
American (AMR)
AF:
AC:
1329
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
37
AN:
3466
East Asian (EAS)
AF:
AC:
0
AN:
5168
South Asian (SAS)
AF:
AC:
15
AN:
4818
European-Finnish (FIN)
AF:
AC:
3
AN:
10604
Middle Eastern (MID)
AF:
AC:
16
AN:
294
European-Non Finnish (NFE)
AF:
AC:
771
AN:
68004
Other (OTH)
AF:
AC:
245
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
605
1210
1814
2419
3024
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
188
376
564
752
940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
126
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.